IL6 and systemic sclerosis: Elevated levels of IL-6 and TNFα have indeed been reported in the serum of SSc patients in several studies [51,52], and both cytokines are associated with fibrotic processes [53,54], disease progression, and the occurrence of interstitial lung disease [55,56], especially in dcSSc patients.